Skip to main content
. Author manuscript; available in PMC: 2010 Jun 15.
Published in final edited form as: Clin Cancer Res. 2009 Jun 9;15(12):4165–4173. doi: 10.1158/1078-0432.CCR-09-0119

Figure 1.

Figure 1

Association between Val16Ala polymorphism and breast cancer survival. Shown are Kaplan-Meier survival curves for 10-year survival. (a) Combined analysis of the US and Norwegian Cohorts (n = 573). Log-rank test: P = 0.003. (b) US Cohort (n = 244). Log-rank test: P = 0.038. (c) Norwegian Cohort (n = 329). Log-rank test: P = 0.039.